AT-278
- Generic Name
- AT-278
AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Arecor Limited
- Target Recruit Count
- 41
- Registration Number
- NCT05754424
- Locations
- 🇦🇹
Clinical Trials Unit, Medical University of Graz, Graz, Austria
AT278 and NovoRapid® in Glucose Clamp Study
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Arecor Limited
- Target Recruit Count
- 38
- Registration Number
- NCT04660305
- Locations
- 🇦🇹
Clinical Trials Unit, Medical University of Graz, Graz, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath